Radu Constantinescu

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. ncbi request reprint Malignant melanoma in early Parkinson's disease: the DATATOP trial
    Radu Constantinescu
    Department of Neurology, University of Rochester Medical Center, Rochester, NY 14620, USA
    Mov Disord 22:720-2. 2007
  2. ncbi request reprint Impact of pramipexole on the onset of levodopa-related dyskinesias
    Radu Constantinescu
    Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA
    Mov Disord 22:1317-9. 2007
  3. doi request reprint The relationship between CAG repeat length and clinical progression in Huntington's disease
    Bernard Ravina
    Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
    Mov Disord 23:1223-7. 2008
  4. ncbi request reprint Levodopa responsiveness in disorders with parkinsonism: a review of the literature
    Radu Constantinescu
    Department of Neurology, University of Rochester School of Medicine, Rochester, New York, USA
    Mov Disord 22:2141-8; quiz 2295. 2007
  5. ncbi request reprint A randomized study of the bioavailability of different formulations of coenzyme Q(10) (ubiquinone)
    Radu Constantinescu
    Department of Neurology, Clinical Trials Coordination Center, University of Rochester Medical Center, Rochester, New York, USA
    J Clin Pharmacol 47:1580-6. 2007
  6. doi request reprint Malignant melanoma in early-treated Parkinson's disease: the NET-PD trial
    Radu Constantinescu
    Center for Human Experimental Therapeutics, University of Rochester Medical Center, Rochester, New York, USA
    Mov Disord 29:263-5. 2014
  7. ncbi request reprint Assistive devices for gait in Parkinson's disease
    Radu Constantinescu
    Department of Neurology, University of Rochester School of Medicine, 1351 Mt Hope Avenue, Suite 100, Rochester, NY 14620 3917, USA
    Parkinsonism Relat Disord 13:133-8. 2007

Detail Information

Publications7

  1. ncbi request reprint Malignant melanoma in early Parkinson's disease: the DATATOP trial
    Radu Constantinescu
    Department of Neurology, University of Rochester Medical Center, Rochester, NY 14620, USA
    Mov Disord 22:720-2. 2007
    ..The standardized event ratio was 3.3 (95% confidence interval, 1.1-7.8), indicating that incidence of malignant melanoma was higher than expected. We found no association between levodopa therapy and the incidence of melanoma...
  2. ncbi request reprint Impact of pramipexole on the onset of levodopa-related dyskinesias
    Radu Constantinescu
    Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA
    Mov Disord 22:1317-9. 2007
    ....
  3. doi request reprint The relationship between CAG repeat length and clinical progression in Huntington's disease
    Bernard Ravina
    Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
    Mov Disord 23:1223-7. 2008
    ..This finding may account for the variable results from previous studies examining CAGn and progression. Adjusting for CAGn may be important for clinical trials...
  4. ncbi request reprint Levodopa responsiveness in disorders with parkinsonism: a review of the literature
    Radu Constantinescu
    Department of Neurology, University of Rochester School of Medicine, Rochester, New York, USA
    Mov Disord 22:2141-8; quiz 2295. 2007
    ..Efforts should be directed toward better defining LR when used for diagnostic purposes and in scientific publications...
  5. ncbi request reprint A randomized study of the bioavailability of different formulations of coenzyme Q(10) (ubiquinone)
    Radu Constantinescu
    Department of Neurology, Clinical Trials Coordination Center, University of Rochester Medical Center, Rochester, New York, USA
    J Clin Pharmacol 47:1580-6. 2007
  6. doi request reprint Malignant melanoma in early-treated Parkinson's disease: the NET-PD trial
    Radu Constantinescu
    Center for Human Experimental Therapeutics, University of Rochester Medical Center, Rochester, New York, USA
    Mov Disord 29:263-5. 2014
    ..The objective of this work was to assess the incidence of malignant melanoma in a PD cohort...
  7. ncbi request reprint Assistive devices for gait in Parkinson's disease
    Radu Constantinescu
    Department of Neurology, University of Rochester School of Medicine, 1351 Mt Hope Avenue, Suite 100, Rochester, NY 14620 3917, USA
    Parkinsonism Relat Disord 13:133-8. 2007
    ..We review the available literature and provide practical information about available mobility assistive devices for patients with PD...